Drug brand name changed due to mix-ups identified through reports to USP and FDA Reports to USP's MEDMARX and Medication Errors Reporting Program and the FDA helped to identify a serious problem involving mix-ups between Reminyl, a drug used for Alzheimer's and Amaryl, a drug used to treat diabetes. As a result, the Reminyl brand name is changing to Razadyne.